Corvus Pharmaceuticals
CRVS
CRVS
53 hedge funds and large institutions have $250M invested in Corvus Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 15 increasing their positions, 16 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
7% less capital invested
Capital invested by funds: $267M → $250M (-$17.4M)
Holders
53
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$18.2M | |
| 2 | +$5.97M | |
| 3 | +$516K | |
| 4 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$304K |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$230K |
Top Sellers
| 1 | -$6.12M | |
| 2 | -$740K | |
| 3 | -$732K | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$368K |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$223K |